LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1994 | 06-1994 | 12-1993 | 03-1993 | 12-1992 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 18,673 | 7,699 | 7,699 | 12,349 |
| Marketable Securities | N/A | 0 | 0 | 0 | 1,100 |
| Other current assets | 0 | 173 | 154 | 154 | 188 |
| TOTAL | $N/A | $18,846 | $7,853 | $7,853 | $13,637 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 468 | 430 | 430 | 326 |
| TOTAL | $N/A | $468 | $430 | $430 | $326 |
| Total Assets | $N/A | $21,857 | $10,102 | $10,102 | $15,269 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 660 | 778 | 778 | 221 |
| Accrued Expenses | N/A | 288 | 299 | 299 | 179 |
| TOTAL | $N/A | $1,539 | $1,539 | $1,539 | $400 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $2,047 | $1,625 | $1,625 | $14 |
| Total Liabilities | $N/A | $3,586 | $3,164 | $3,164 | $414 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 86 | 8 | 8 | 8 |
| Retained earnings | N/A | -25,817 | -19,910 | -19,910 | -11,963 |
| Other shareholders' equity | 0 | -943 | 56 | 56 | 344 |
| TOTAL | $N/A | $18,271 | $6,938 | $6,938 | $14,855 |
| Total Liabilities And Equity | $0 | $21,857 | $10,102 | $10,102 | $15,269 |